[Leukemia with hepatosplenic fungal disease: two cases report and literature review].

Qian Wang,Xudong Wei,Q. Yin

2011-10-01

Abstract:

What problem does this paper attempt to address?

Progress in diagnosis and treatment of Birt-Hogg-Dubé syndrome

Shushi Meng,Yanguo Liu,Jun Wang

DOI: https://doi.org/10.3760/cma.j.issn.1673-4386.2018.05.015

2018-01-01

International Journal of Genetics

Abstract:Birt-Hogg-Dubé (BHD)syndrome is an autosomal dominant genetic disorder characterized by fibrofolliculoma,trichodiscomas,renal tumor,pulmonary cysts and spontaneous pneumothorax.The gene for BHD syndrome is the FLCN gene.Diagnostic criteria for the disease involve gene testing,clinical manifestations,and family history.In addition to the routine treatment of various clinical manifestations,there have been progresses in targeted therapies for genetic defect.
Guiding the future of clinical care and clinical research in Birt-Hogg-Dubé

Michel Alchoueiry,W. Clark Lambert,Elizabeth P. Henske

DOI: https://doi.org/10.1038/s41431-024-01696-7

2024-09-29

European Journal of Human Genetics

Abstract:Birt-Hogg-Dubé (BHD) syndrome is an autosomal dominant disorder caused by germline loss-of-function mutations in the Folliculin gene ( FLCN ). The Folliculin (FLCN) protein forms a complex with the folliculin interacting proteins 1 and 2 (FNIP1, FNIP2) and functions in multiple signaling and metabolic pathways such as AMPK-mediated energy sensing and mTORC1-dependent cell proliferation. BHD is associated with benign skin tumors (~90% penetrance by age 70 years), renal cell carcinoma (RCC, penetrance of 15–30%), and cystic lung disease (24–48% penetrance). The lung cysts can rupture spontaneously, leading to pneumothorax (median age at first pneumothorax is 34 years with a range from 7 to 78 yrs) [1]. It is estimated that 10% of individuals with pneumothorax have an underlying genetic syndrome with BHD having the highest prevalence. The RCC in BHD can have distinctive features, including chromophobe-oncocytic morphology [2]. Geilswijk et al. [3] have developed an international consensus clinical practice guidelines for the diagnosis, surveillance, and management of individuals with BHD. These guidelines are much-needed, especially since recent data from a population-based health care setting indicates an incidence of loss-of-function FLCN mutation, about 60-fold higher than prior estimates. Accurate diagnosis is often challenging: the skin manifestations can be subtle and difficult to diagnose, and age-dependent penetrance might not be evident until later adulthood, after a pneumothorax or renal tumor has developed.

genetics & heredity,biochemistry & molecular biology
Birt-Hogg Dube Syndrome: Prevalence and Clinical Characteristics Determined from a National Referral Centre

Clarke,A.,Lynn,E.,Murphy,D.,Keane,M. P.,Mccarthy,C.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa4870

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Introduction: Birt-Hogg Dube Syndrome (BHD) is a rare autosomal dominant condition caused by pathogenic variants in the folliculin (FLCN) gene. There is a wide heterogeneity in phenotype. Reported worldwide prevalence is 2 cases per million. The aims of this study were to estimate BHD prevalence in a single country, and examine correlation between lung function, CT scans and clinical outcomes. Methods: Data for BHD patients was identified and collated from the ERN-Lung centre at St. Vincent's University Hospital, Dublin. Results: 51 cases of BHD were identified; 43%(n=22) male and 57%(n=29) female. Median age was 51 years (range 17-82). Referrals were made for pneumothorax (29%,n=15), incidental pulmonary cysts on imaging(27%,n=14),screening due to family history (37%,n=19), fibrofolliculomas(4%,n=2) and due to kidney lesions (2%, n=1). The most common genotypes were c.17_21del (18%),c.1285dupC (10%) and c.469_471del (4%).25%(n=13) have fibrofolliculoma and 16%(n=8) have renal lesions.41%(n=21) had history of pneumothorax. There was no correlation between pneumothorax and gene variant. Mean FEV1 and DLCO were 90.80% (SD+/-13.02) and 78.41% (SD+/-15.64)respectively. Mean cyst burden score was 2% of total lung volume (range 0.1-5.4%). Cyst burden did not correlate with FEV1%(R2=0.079,p=0.429) or DLCO(R2=0.023,p=0.676). Patients with history of pneumothorax were more likely to have higher cyst burden score independent of lung function (mean=2.37% vs 0.9%,p=0.08). Conclusion: BHD is likely under-recognised. While reported prevalence worldwide is 2 cases per million, we identified 51 individuals with BHD in our clinic, representing a minimum estimate of 10.13 cases per million

respiratory system
Clinical relevance of FLCN mutations in Asian patients with Birt-Hogg-Dube syndrome

Liu,J.,Jia,N.,Huang,H.,Pan,Y.,Li,M.,Mccormack,F. X.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5208

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Introduction: Birt-Hogg-Dubé syndrome (BHDS) is a rare, autosomal dominant genetic disorder featured by the development of fibrofolliculoma, renal cell carcinoma and lung cysts. Methods:From 2019 to 2024,52 patients with BHDS have been diagnosed in our department. The diagnosis of 47 patients were confirmed via direct FLCN sequencing, and three according to their characteristic clinical and radiological presentations. Result:There were 52 (45 Females, 7Males) patients diagnosed with BHD in our group, the average age was 48.41 years (range: 19-75 y). All patients are Asian, Three patients were ex-smokers, 34.62%(18/52) patients had a family history of pulmonary bulla or pneumothorax. 63.46%(33/52) patients have experienced less of breath, and 53.85% (28/52)patients has a cough experience.only four patients had skin lesions at the time of diagnosis ,and only three paient had renal hamartoa occurred. CT scans were available for 52 patients,65.38%(34/52) Patients had a history of recurrent symptomatic pneumothorax. 29 out of 52 patients had pulmonary function tests, Other patients did not have lung function done because they had a recurrent pneumothorax within six months or for other reasons. Among 52 patients, with 5 case unknow, 60.71% (17/28) patients were found to have alveoli in pathological diagnosis. In 43 out of the 52 patients ,FLCN mutations were identifird as likely or confirmed pathogenicity. Conclusions: The proportion of Asian patients with skin symptoms and renal symptoms is low, and further diagnosis and treatment should be combined with family history, FLCN mutation test and clinical characteristics.

respiratory system
New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome

John C Kennedy,Damir Khabibullin,Yoseph Boku,Wei Shi,Elizabeth P Henske

DOI: https://doi.org/10.1055/s-0040-1708500

Abstract:Birt-Hogg-Dubé (BHD) syndrome is an autosomal dominant disorder caused by germline loss-of-function mutations in Folliculin gene (FLCN). BHD is characterized by lower lobe-predominant pulmonary cysts with risk of pneumothorax, benign skin tumors (fibrofolliculomas), and renal cell carcinoma, often of an unusual chromophobe/oncocytic hybrid histology. The FLCN protein functions in multiple signaling and metabolic pathways including positive regulation of mechanistic target of rapamycin complex 1 (mTORC1) activity via FLCN's GTPase (GAP) activity for Rag C, positive regulation of Wnt signaling (in mesenchymal cells), and negative regulation of TFE3 nuclear localization. Therefore, FLCN-deficient cells are predicted to have reduced mTORC1 and Wnt activity and enhanced TFE3 activity. Folliculin also has functions in autophagy, mitochondrial biogenesis, cell-cell adhesion, 5' AMP activated protein kinase activity, and other pathways. The specific contributions of these pathways to the lung manifestations of BHD are largely unknown. This review is focused on the pulmonary manifestations of BHD, highlighting selected recent advances in elucidating the cellular functions of FLCN and current hypotheses related to the pathogenesis of cystic lung disease in BHD, including the "stretch hypothesis." We also discuss important knowledge gaps in the field, including the genetic, cellular and physical mechanisms of cyst pathogenesis, and the timing of cyst initiation, which may occur during lung development.
Complex roles for P-selectin in the pathophysiology of glomerulonephritis.

H. Brady

DOI: https://doi.org/10.1097/00041552-199609000-00008

1996-09-01

Abstract:
Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors

Jialong Wu,Jian Lu,Chin-Lee Wu,Min Lu

DOI: https://doi.org/10.1053/j.semdp.2024.01.008

IF: 3.893

2024-01-08

Seminars in Diagnostic Pathology

Abstract:Birt-Hogg-Dubé syndrome (BHD) represents a rare autosomal dominant tumor predisposition syndrome characterized by skin lesions, lung cysts, and renal tumors. The predominant histological subtypes of BHD-related renal tumors include hybrid oncocytoma-chromophobe tumors, oncocytomas, and chromophobe renal cell carcinomas, all exhibiting eosinophilic/oncocytic features. Immunohistochemistry staining for KIT (CD117) and CK7 exhibits variability in these tumor types. Germline mutations in FLCN have been consistently identified. Generally, patients with BHD demonstrate a favorable prognosis with minimal metastatic potential. Nonetheless, the comprehensive elucidation of pathological characteristics of BHD remains incomplete, particularly in BHD-associated renal tumors that deviate from the previously identified subtypes, thereby complicating the differential diagnosis. In this review, we provide a comprehensive overview of BHD encompassing epidemiology, clinical manifestations, genetic and molecular pathogenesis, as well as clinical diagnostic modalities. Emphasis is placed on clinicopathological features, specifically focusing on BHD-associated renal tumors. Collectively, this review aims to present the latest insights into BHD which benefits in the early detection, therapeutic decision-making, prognosis prediction in BHD cases, and deepen the understanding of sporadic renal tumors.

pathology,medical laboratory technology
Clinical and genetic characteristics of 100 consecutive patients with Birt-Hogg-Dubé syndrome in Eastern Chinese region

Daiju Hu,Rui Wang,Jinli Liu,Xianmeng Chen,Xianliang Jiang,Jun Xiao,Jay H. Ryu,Xiaowen Hu

DOI: https://doi.org/10.1186/s13023-024-03360-1

2024-09-22

Orphanet Journal of Rare Diseases

Abstract:Although an increasing number of patients with Birt-Hogg-Dubé syndrome (BHD) are being recognized in China, clinical and genetic characteristics are not well-defined. In addition, revised diagnostic criteria for the Chinese population was proposed in 2023, we aimed to explore their utility in clinical practice at a rare lung disease center.

genetics & heredity,medicine, research & experimental
Correction To: Birt-Hogg-Dubé Syndrome Encountered at Rare Lung Disease Clinic in Anhui Province, China

Guofeng Zhang,Jinli Liu,Yushuo Wang,Yue Wang,Xianliang Jiang,Yan Peng,Jun Xiao,Wei,Bing Shen,Long Yi,Jay H. Ryu,Xiaowen Hu

DOI: https://doi.org/10.1186/s13023-022-02438-y

2022-01-01

Orphanet Journal of Rare Diseases

Abstract:Background Diagnosis of rare diseases remains a challenge in China. We describe our experience with Birt-Hogg-Dube syndrome (BHDS) encountered at a Rare Lung Disease Clinic recently established in China. Methods After the first patient with BHDS was recognized in 2017, a Rare Lung Disease Clinic with a multidisciplinary team of specialists was established. We retrospectively analyzed the data of consecutive patients with BHDS encountered from inception to December 2021. Results There were 1, 1, 15, 12 and 21 cases with BHDS diagnosed from year 2017 to 2021, respectively. All 50 patients (34 women) were of Han race with a mean age of 47.4 years. The common manifestations were pulmonary cysts (98%), pneumothorax (54%) and skin lesions (68%). Renal cancer was detected in two patients and renal angiomyolipoma in four other patients. The main presentations leading to diagnosis were pneumothorax (42%), family screening (36%), and lung cysts identified on radiologic imaging (20%). The average delay in diagnosis was 8.3 years, and 4.7 years in patients with only pulmonary cysts. The most frequent pathogenic variant was c.1285del/dup on exon 11 (23%) among 44 patients confirmed by genetic testing. Renal cancer has not been found on follow-up surveillance thus far. Conclusions Increasing number of patients with BHDS are being recognized in China, facilitated by establishment of a Rare Lung Disease Clinic. Pulmonary cysts and pneumothorax were commonly encountered features, but skin lesions appeared to be more prevalent in Chinese subjects than previously reported in other Asian countries.
Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report

Jun Li,Fan Liu,Xuguang Liu,Yu Hu,Zheng Liu,Yaqi Shen,Jie Wan

DOI: https://doi.org/10.1007/s00432-022-04417-z

Abstract:Background: Birt-Hogg-Dubé (BHD) syndrome is a rare autosomal dominant tumor syndrome caused by Folliculin (FLCN) gene mutation. The clinical manifestations are diverse, and the renal tumor is the most serious. Case presentation: We report the case of a 51-year-old female with multiple space-occupying lesions in both kidneys, as well as bilateral renal cysts and multiple lung cysts. The resected tumors were finally diagnosed as bilateral renal hybrid oncocytic/chromophobe tumor (HOCT) and unilateral chromophobe cell carcinoma. A history of pneumothorax surgery 4 years ago was convinced. All of these strongly suggested the possibility of BHD syndrome. Gene test confirmed a heterozygous germline FLCN nonsense mutation (c.1429C > T, p.Arg477Ter). The patient is still doing well after 20 months of follow-up (cut-off date July 2022). Conclusion: This is a case of BHD syndrome presented with bilateral renal tumor, renal cysts, and multiple lung cysts, and confirmed by gene testing. Patients with any combination of one or more of the manifestations should remain alert to the BHD syndrome. Our report will help to deepen the understanding of the clinicopathological features and molecular changes of BHD syndrome.
Familial spontaneous pneumothorax: importance of screening for Birt-Hogg-Dubé syndrome.

Yanguo Liu,Huajie Xing,Yu Huang,Shushi Meng,Jun Wang

DOI: https://doi.org/10.1093/ejcts/ezz171

IF: 4.534

2020-01-01

European Journal of Cardio-Thoracic Surgery

Abstract:OBJECTIVES: The goal of this study was to investigate the prevalence of Birt-Hogg-Dube (BHD) syndrome in patients with familial spontaneous pneumothorax (FSP) and the clinical characteristics of pneumothorax related to BHD syndrome compared with those of primary spontaneous pneumothorax. METHODS: A total of 37 families diagnosed with FSP from 2007 to 2017 were enrolled in this study. The FLCN gene, which is responsible for BHD syndrome, was sequenced using the Sanger method in 25 probands. For the patients with confirmed BHD syndrome-related pneumothorax, clinical characteristics including the median onset age of pneumothorax, the male-to-female ratio, the mean height and body mass index (BMI) and the recurrence rate after different treatment modalities were obtained and compared with those of patients with primary spontaneous pneumothorax. RESULTS: Of the 25 probands with FSP, 16 [64.0%, 95% confidence interval (CI) 43.8-84.2%] harboured FLCN germline mutations. In the patients with BHD syndrome-related pneumothorax, the median onset age of pneumothorax was 34years; the male-to-female ratio was 1.3:1; and the mean height and BMI were 167.0 +/- 8.6 cm and 23.6 +/- 3.4 kg/m(2), respectively. These characteristics were significantly different from those in patients with primary spontaneous pneumothorax from the same centre. The recurrence rate of BHD syndrome-related pneumothorax after conservative therapy was 53.1% (95% CI 38.6-67.5%) compared with 9.1% (95% CI 0-19.4%) after surgical treatment. CONCLUSIONS: BHD syndrome is one of the most common causes of FSP. Patients with FSP should be recommended for mutation screening for the FLCN gene to facilitate early diagnosis and proper intervention.
A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions

Christina Shabet,Meera Kattapuram,Anna Burton,Renata Thoeny,Hailey Nielsen,Marie Louise Accardo,Emily H. Smith,Erika Koeppe,Tobias Else,Kelly B. Cha

DOI: https://doi.org/10.1007/s10689-024-00402-2

2024-06-02

Familial Cancer

Abstract:Birt-Hogg-Dubé (BHD) syndrome is a genetic condition caused by pathogenic variants in the FLCN gene resulting in benign skin lesions, spontaneous pneumothorax, and increased risk for a variety of renal tumors. Skin manifestations of BHD include trichodiscoma (TD) and fibrofolliculoma (FF), which may represent the same pathologic entity. These lesions can identify BHD patients, who upon positive genetic testing can be considered for life-long surveillance for renal neoplasms.

oncology,genetics & heredity
AB111. Features of Birt-Hogg-Dubé Syndrome Patients in East Asian Countries

Teng Li,Xinghui Ning,Shuanghe Peng,Jiangyi Wang,Kan Gong

DOI: https://doi.org/10.3978/j.issn.2223-4683.2015.s111

2015-01-01

Translational Andrology and Urology

Abstract:Objective Birt-Hogg-Dube (BHD) syndrome is an inherited renal cancer syndrome caused by mutations in FLCN gene and characterized by the presence of fibrofolliculomas, pulmonary cysts, spontaneous pneumothoraces and renal cell carcinomas. Only a few BHD syndrome cases were reported from Asian countries, more cases are needed to analysis the genotype-phenotype of this disease.
Novel Germline Mutations in FLCN Gene Identified in Two Chinese Patients with Birt–Hogg–Dubé Syndrome

Teng Li,Xianghui Ning,Qun He,Kan Gong

DOI: https://doi.org/10.1186/s40880-016-0172-5

2017-01-01

Abstract:Birt–Hogg–Dubé (BHD) syndrome, a hereditary renal cancer syndrome caused by mutations in the folliculin (FLCN) gene, is characterized by the presence of fibrofolliculomas, pulmonary cysts, spontaneous pneumothorax, and renal cell carcinoma (RCC). Few BHD syndrome cases have been reported in Asian countries, and cutaneous presentations are relatively rare in Asian patients. Asian BHD patients may be misdiagnosed due to their atypical manifestations. Here, we report two Chinese BHD patients with novel FLCN mutations (c.946-947delAG in exon 9 and c.770-772delCCT in exon 7). Both of them had RCC and spontaneous pneumothorax without fibrofolliculomas. In patients with RCC and pulmonary cysts but without cutaneous lesions, screening for mutations in the FLCN gene should be performed, especially for those with a family history of RCC or pulmonary cysts (pneumothorax).
What Are the Best Criteria for Birt–Hogg–Dubé Syndrome‐related Pneumothorax?

H. Rosie Xing,Deruo Liu,Chaoyang Liang

DOI: https://doi.org/10.1111/resp.13717

IF: 6.9

2019-01-01

Respirology

Abstract:We read with great interest the study by Ebana et al.1 in the April 2018 issue of Respirology. A scoring system was established to separate patients with Birt–Hogg–Dubé (BHD) syndrome from patients with primary spontaneous pneumothorax. We agree that this system could be quite useful in clinical practice, but we have a further suggestion. In this study, only patients who were suspected of BHD syndrome underwent sequencing of the FLCN gene. Potential BHD syndrome was judged by the familial history of pneumothorax and/or characteristic appearance of multiple lung cysts on chest computed tomography (CT). So, pneumothorax patients without family history or typical CT finding were grouped as non-BHD related directly. However, according to the study by Schmidt et al.,2 in a group of 53 previously diagnosed BHD families, 25 families had members who developed spontaneous pneumothorax. Among the 25 families, 13 had one member who developed pneumothorax while 12 had more than one, which means that over half of the BHD-related pneumothorax presented as sporadic pneumothorax (without a clear family history of pneumothorax). Furthermore, in this cohort, not all BHD patients had lung cysts on chest CT scan, even when pneumothorax had occurred (see family 246 in table 1 from Reference 2). The ‘typical’ chest CT finding of BHD patients is not a widely accepted or standard definition. It has been reported that the lung cysts and pneumothorax in BHD patients are age-dependent manifestations and lung cysts are not necessarily related to pneumothorax.3 Hence, we believe that the inclusion criteria used by the authors could not select BHD-related pneumothorax patients effectively from their study cohort. From the perspective of medical statistics, in order to set up a new diagnostic tool, there should be an already existing gold standard, which could be used to obtain a definitive diagnosis for a particular disease, such as pathology result for cancer or culture result for infection. In this case, in order to set up a prediction model, the gold standard should be used to definitely clarify a pneumothorax patient to be BHD-related or not, then the new prediction model could be compared and the sensitivity and specificity could be calculated. For genetic disorders, DNA sequencing is the gold standard for diagnosis. So, we believe that the authors should perform FLCN sequencing for every pneumothorax patient in their study cohort, regardless of the family history or the CT findings. In conclusion, we propose that DNA sequencing should be used in this study as gold standard in order to establish a reliable prediction model.
Lymphoplasmacytic lymphoma in a patient with Birt–Hogg–Dubé syndrome

Keiji Kurata,Hisayuki Matsumoto,Naoe Jimbo,Kimikazu Yakushijin,Katsuya Yamamoto,Mitsuhiro Ito,Yuji Nakamachi,Hiroshi Matsuoka,Jun Saegusa,Kuniaki Seyama,Tomoo Itoh,Hironobu Minami

DOI: https://doi.org/10.1007/s12185-020-02970-2

2020-08-12

International Journal of Hematology

Abstract:Birt–Hogg–Dubé (BHD) syndrome is an autosomal dominant disease characterized by benign skin hamartomas, pulmonary cysts leading to spontaneous pneumothorax, and an increased risk of renal cancer. BHD syndrome is caused by germline mutations in the folliculin (FLCN) gene, a putative tumor suppressor, which result in loss of function of the folliculin protein and may cause cancer predisposition. In a 45-year-old woman with anemia, lymphadenopathy, and a history of recurrent spontaneous pneumothorax, 18F-FDG PET/CT detected diffuse and slight 18F-FDG accumulation in the bone marrow, enlarged spleen, and systemic multiple enlarged lymph nodes. Genetic examination identified a germline nonsense mutation [c.998C > G (p.Ser333*)] on exon 9 of FLCN. Pathological examination of the lymph node revealed a diffuse neoplastic proliferation of plasmacytoid lymphocytes. The neoplastic lymphoid cells were positive for CD20, CD138, and light chain kappa as per immunohistochemistry and mRNA in situ hybridization, and a MYD88 gene mutation [c.755T > C (p.L252P)] was identified. Accordingly, she was diagnosed with lymphoplasmacytic lymphoma concomitant with BHD syndrome. To the best of our knowledge, this is the first report describing the development of hematological malignancy in a patient with BHD syndrome. The FLCN mutation might contribute lymphomagenesis as an additional mutation cooperating with the MYD88 mutation.

hematology
An unconstrained monitoring system for home rehabilitation. A wireless heart/respiratory rate sensor accessible to home-visit therapists.

Y. Masuda,M. Sekimoto,M. Nambu,Y. Higashi,T. Fujimoto,K. Chihara,T. Tamura

IEEE Engineering in Medicine and Biology Magazine

Abstract:
A Novel FLCN Intragenic Deletion Identified by NGS in a BHDS Family and Literature Review

Minghui Cai,Xinxin Zhang,Lizhen Fan,Shuwen Cheng,Abdukahar Kiram,Shaoqin Cen,Baofu Chen,Minhua Ye,Qian Gao,Chengchu Zhu,Long Yi,Dehua Ma

DOI: https://doi.org/10.3389/fgene.2021.636900

IF: 3.7

2021-01-01

Frontiers in Genetics

Abstract:Birt–Hogg–Dubé syndrome (BHDS, MIM #135150), caused by germline mutations of FLCN gene, is a rare autosomal dominant inherited disorder characterized by skin fibrofolliculomas, renal cancer, pulmonary cysts and spontaneous pneumothorax. The syndrome is considered to be under-diagnosed due to variable and atypical manifestations. Herein we present a BHDS family. Targeted next generation sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA) revealed a novel FLCN intragenic deletion spanning exons 10-14 in four members including the proband with pulmonary cysts and spontaneous pneumothorax, one member with suspicious skin lesions and a few pulmonary cysts, as well as two asymptomatic family members. In addition, a linkage analysis further demonstrated one member with pulmonary bullae to be a BHDS-ruled-out case, whose bullae presented more likely as an aspect of paraseptal emphysema. Furthermore, the targeted NGS and MLPA data including our previous and present findings were reviewed and analyzed to compare the advantages and disadvantages of the two methods, and a brief review of the relevant literature is included. Considering the capability of the targeted NGS method to detect large intragenic deletions as well as determining deletion junctions, and the occasional false positives of MLPA, we highly recommend targeted NGS to be used for clinical molecular diagnosis in suspected BHDS patients.
Prevalence of Birt-Hogg-Dubé Syndrome Determined Through Epidemiological Data on Spontaneous Pneumothorax and Bayes Theorem

Marie-Eve Muller,Cécile Daccord,Patrick Taffé,Romain Lazor

DOI: https://doi.org/10.3389/fmed.2021.631168

IF: 3.9

2021-04-27

Frontiers in Medicine

Abstract:Background: Birt-Hogg-Dubé syndrome (BHD) is a rare inherited disorder characterized by cutaneous fibrofolliculomas, multiple pulmonary cysts, recurrent spontaneous pneumothorax (SP), and renal tumors. More than 40 years after its description, the prevalence of BHD in the general population remains unknown. This study aimed at determining the prevalence of BHD by applying the Bayes theorem of conditional probability to epidemiological data on SP. Methods: We performed a meta-analysis of published data on: (1) the probability of having BHD among patients with apparent primary SP (4 studies), (2) the incidence rate of primary SP in the general population (9 studies), and (3) the probability of experiencing a SP in BHD (16 studies). Results were corrected for SP relapses, stratified by gender and year of study publication (before and after 2000), and computed with the Bayes equation. Results: The probability of having BHD among patients with apparent primary SP was 0.09 (95% confidence interval: 0.07, 0.11) or 9%. It was 0.20 (0.14, 0.27) in women and 0.05 (0.04, 0.07) in men. The incidence rate of primary SP in the general population was 8.69 (6.58, 11.46) per 100,000 person-years (p-y). It was 3.44 (2.36, 4.99) per 100,000 p-y in women and 13.96 (10.72, 18.18) per 100,000 p-y in men, and was about 2 times higher in studies published after 2000 than in those published before 2000. The probability of experiencing at least one SP among patients with BHD was 0.43 (0.31, 0.54) or 43%, without gender difference. By combining these data in the Bayes equation, we found a prevalence of BHD in the general population of 1.86 (1.16, 3.00) per million, with values of 1.86 (1.02, 3.39) per million in men, and 1.88 (0.97, 3.63) per million in women. Conclusion: The prevalence of BHD in the general population is about 2 cases per million, without difference between genders.

medicine, general & internal
Cardiac rhabdomyoma: a rare feature of Birt-Hogg-Dubé syndrome

Florence Petit,Louise Devisme,Dimitri Tchernitchko,Olivia Domanski,Cecilia Gonzalez-Corcia,Lidwine Wemeau-Stervinou,Sophie Lejeune

DOI: https://doi.org/10.1136/jmg-2024-110349

2024-11-25

Abstract:Birt-Hogg-Dubé syndrome (BHDS) is a rare autosomal disorder, primarily characterised in adults by cutaneous features, pulmonary cysts that predispose to spontaneous pneumothorax and renal tumours. The syndrome is caused by pathogenic variants in the FLCN tumour suppressor gene, which plays a role in the mammalian target of rapamycin (mTOR) signalling pathway. We present the case of a newborn infant diagnosed with BHDS, who died of sudden cardiac death due to complications from cardiac rhabdomyoma. This is only the second reported case of such an association. Both cases were initially misdiagnosed with tuberous sclerosis complex, highlighting the diagnostic challenges. We discuss this differential diagnosis and suggest that cardiac rhabdomyomas, although rare, may be associated with BHDS and potentially life threatening. Therefore, we recommend cardiac screening in newborns at risk.

[Leukemia with hepatosplenic fungal disease: two cases report and literature review].

Progress in diagnosis and treatment of Birt-Hogg-Dubé syndrome

Guiding the future of clinical care and clinical research in Birt-Hogg-Dubé

Birt-Hogg Dube Syndrome: Prevalence and Clinical Characteristics Determined from a National Referral Centre

Clinical relevance of FLCN mutations in Asian patients with Birt-Hogg-Dube syndrome

New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome

Complex roles for P-selectin in the pathophysiology of glomerulonephritis.

Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors

Clinical and genetic characteristics of 100 consecutive patients with Birt-Hogg-Dubé syndrome in Eastern Chinese region

Correction To: Birt-Hogg-Dubé Syndrome Encountered at Rare Lung Disease Clinic in Anhui Province, China

Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report

Familial spontaneous pneumothorax: importance of screening for Birt-Hogg-Dubé syndrome.

A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions

AB111. Features of Birt-Hogg-Dubé Syndrome Patients in East Asian Countries

Novel Germline Mutations in FLCN Gene Identified in Two Chinese Patients with Birt–Hogg–Dubé Syndrome

What Are the Best Criteria for Birt–Hogg–Dubé Syndrome‐related Pneumothorax?

Lymphoplasmacytic lymphoma in a patient with Birt–Hogg–Dubé syndrome

An unconstrained monitoring system for home rehabilitation. A wireless heart/respiratory rate sensor accessible to home-visit therapists.

A Novel FLCN Intragenic Deletion Identified by NGS in a BHDS Family and Literature Review

Prevalence of Birt-Hogg-Dubé Syndrome Determined Through Epidemiological Data on Spontaneous Pneumothorax and Bayes Theorem

Cardiac rhabdomyoma: a rare feature of Birt-Hogg-Dubé syndrome